title: Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications.
authors.affiliation: Clinical Research and Development Diagnostics, Schering AG, Berlin, Germany.
authors.forename: H P
authors.initials: HP
authors.lastname: Niendorf
authors.forename: A
authors.initials: A
authors.lastname: Alhassan
authors.forename: V R
authors.initials: VR
authors.lastname: Geens
authors.forename: W
authors.initials: W
authors.lastname: Clauss
mesh_terms: D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000009:adverse effects*; D004338:Drug Combinations; D019786:Gadolinium DTPA; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging; D008536:Meglumine / Q000009:adverse effects*; D009942:Organometallic Compounds / Q000009:adverse effects*; D004369:Pentetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D008536:Meglumine; D004369:Pentetic Acid; D019786:Gadolinium DTPA